Approaches sponsors, CROs, and investigators can take from the DMD experience.
Michael G. Kelly, PhD
Advertisement
Chief Scientific Officer, CureDuchenne
Articles by Michael G. Kelly, PhD
Advertisement
Latest Updated Articles
Rare Disease Clinical Trials: Strategies Learned from Duchenne Muscular DystrophyPublished: October 14th 2022 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Long-Term APEX Trial Data Reinforce Tremfya’s Sustained Psoriatic Arthritis Control and Structural Protection
2
Choosing Nontraditional Digital Platforms for Patient Recruitment
3
Tailoring Recruitment Strategies Across Platforms and Patient Populations
4
Ziihera Combinations Show Significant Survival Benefits in Phase III HER2+ GEA Trial
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
